Cite
HARVARD Citation
Song, Z. et al. (2018). The antimalarial compound ELQ‐400 is an unusual inhibitor of the bc1 complex, targeting both Qo and Qi sites. FEBS letters. 592 (8), pp. 1346-1356. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Song, Z. et al. (2018). The antimalarial compound ELQ‐400 is an unusual inhibitor of the bc1 complex, targeting both Qo and Qi sites. FEBS letters. 592 (8), pp. 1346-1356. [Online].